Cargando…

Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma

CONTEXT: Management of sporadic medullary thyroid microcarcinoma smaller than 1 cm (micro-MTC) is controversial because of conflicting reports of prognosis. As these cancers are often diagnosed incidentally, they pose a management challenge when deciding on further treatment and follow-up. OBJECTIVE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kesby, Nicholas, Mechera, Robert, Fuchs, Talia, Papachristos, Alexander, Gild, Matti, Tsang, Venessa, Clifton-Bligh, Roderick, Robinson, Bruce, Sywak, Mark, Sidhu, Stan, Chou, Angela, Gill, Anthony J, Glover, Anthony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Clinical Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505538/ https://www.ncbi.nlm.nih.gov/pubmed/36964913 http://dx.doi.org/10.1210/clinem/dgad173

Ejemplares similares

A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis
por: Fuchs, Talia L., et al.
Publicado: (2020)

Lobectomy and completion thyroidectomy rates increase after the 2015 American Thyroid Association Differentiated Thyroid Cancer Guidelines update
por: Worrall, Benjamin J, et al.
Publicado: (2023)

Molecular Markers Guiding Thyroid Cancer Management
por: Nylén, Carolina, et al.
Publicado: (2020)

Selpercatinib Treatment of RET-Mutated Thyroid Cancers Is Associated With Gastrointestinal Adverse Effects
por: Tsang, Venessa, et al.
Publicado: (2022)

Medullary Thyroid Cancer: Updates and Challenges
por: Gild, Matti L, et al.
Publicado: (2023)

Infiltrative lymphocytic hypophysitis successfully treated with rituximab and mycophenolate mofetil
por: Lin, Mike, et al.
Publicado: (2020)

Metastatic papillary thyroid cancer to cerebellum with incidental medullary microcarcinoma
por: Wang, Mawson, et al.
Publicado: (2022)

Development of a novel clinical support tool for active surveillance of low risk papillary thyroid cancer
por: White, Eleanor, et al.
Publicado: (2023)

Unexpected deaths after endocrine surgery: learning from rare events using a national audit of surgical mortality
por: Chui, Juanita N, et al.
Publicado: (2022)

TERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomas
por: Bullock, Martyn, et al.
Publicado: (2016)

Translational Utility of Liquid Biopsies in Thyroid Cancer Management
por: Wijewardene, Ayanthi A., et al.
Publicado: (2021)

Thyroid Hormone Abuse in Elite Sports: The Regulatory Challenge
por: Gild, Matti L, et al.
Publicado: (2022)

Immune Related Adverse Events of the Thyroid – A Narrative Review
por: Muir, Christopher A., et al.
Publicado: (2022)

A Case of Medullary Microcarcinoma in the Setting of Cowden’s Syndrome
por: Donato, Umberto M, et al.
Publicado: (2022)

International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma
por: Xu, Bin, et al.
Publicado: (2022)

Clinical and ultrasonographic features of medullary thyroid microcarcinomas compared with papillary thyroid microcarcinomas: a retrospective analysis
por: Li, Xiaoyu, et al.
Publicado: (2020)

Thyroid Hormone Abuse Among Elite Athletes
por: Handelsman, David J, et al.
Publicado: (2023)

Tumour volume is a predictor of lymphovascular invasion in differentiated small thyroid cancer
por: Vikneson, Krishna, et al.
Publicado: (2022)

Synchronous multifocal medullary and papillary thyroid microcarcinoma detected by elastography()
por: Koudounarakis, Eleftherios, et al.
Publicado: (2013)

Synchronous papillary-medullary thyroid microcarcinoma: a case report
por: Medam, Ramapaada Reddy, et al.
Publicado: (2022)

RF11 | PSAT370 I-PET Score: Combining Whole Body Iodine Scan and 18 Fluorodeoxyglucose Positron Emission Topography to Predict Progression in Thyroid Cancer
por: Wijewardene, Ayanthi, et al.
Publicado: (2022)

Noncoding RNA blockade of autophagy is therapeutic in medullary thyroid cancer
por: Gundara, Justin S, et al.
Publicado: (2015)

Phenotypic Differences in Thyroid Immune Related Adverse Events Following Treatment With Immune Checkpoint Inhibitors
por: Muir, Christopher Alan, et al.
Publicado: (2021)

ACTH-secreting medullary thyroid cancer: a case series
por: Wijewardene, Ayanthi A, et al.
Publicado: (2017)

Simultaneous occurrence of medullary and papillary thyroid microcarcinomas: a case series and review of the literature
por: Adnan, Zaina, et al.
Publicado: (2013)

Sporadic medullary microcarcinoma in a male patient with concurrent Hashimoto’s hypothyroidism and Kikuchi disease
por: Choi, Mi-Rim, et al.
Publicado: (2016)

Destabilizing RET in targeted treatment of thyroid cancers
por: Gild, M L, et al.
Publicado: (2015)

Malignant struma ovarii with a robust response to radioactive iodine
por: Gild, M L, et al.
Publicado: (2020)

Clinicopathological characteristics and prognosis of medullary thyroid microcarcinoma: a tumor with a similar prognosis to macrocarcinoma
por: Wu, Xin, et al.
Publicado: (2023)

Utility of the succinate:fumarate ratio for assessing SDH dysfunction in different tumor types()
por: Kim, Edward, et al.
Publicado: (2016)

Unravelling Checkpoint Inhibitor Associated Autoimmune Diabetes: From Bench to Bedside
por: Wu, Linda, et al.
Publicado: (2021)

A Detailed Clinicopathologic Study of ALK-translocated Papillary Thyroid Carcinoma
por: Chou, Angela, et al.
Publicado: (2015)

A Clinicopathologic and Molecular Analysis of Fumarate Hydratase–deficient Pheochromocytoma and Paraganglioma
por: Fuchs, Talia L., et al.
Publicado: (2023)

The diagnosis and management of pheochromocytoma and paraganglioma during pregnancy
por: Clifton-Bligh, Roderick J.
Publicado: (2023)

Response to Letter to the Editor: “Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes”
por: Tsang, Venessa H M, et al.
Publicado: (2020)

Succinate Dehydrogenase Deficiency Is Rare in Pituitary Adenomas
por: Gill, Anthony J., et al.
Publicado: (2014)

15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1–5
por: Benn, Diana E, et al.
Publicado: (2015)

Homozygous Ser-1 to Pro-1 mutation in parathyroid hormone identified in hypocalcemic patients results in secretion of a biologically inactive pro-hormone
por: Hanna, Patrick, et al.
Publicado: (2023)

Sonographic Volumetric Assessment Is a More Accurate Measure Than Maximum Diameter Alone in Papillary Thyroid Cancer
por: Pennington, Thomas E, et al.
Publicado: (2018)

Ultrasonic features of papillary thyroid microcarcinoma and non-microcarcinoma
por: ZHANG, XIAO-LI, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_42grmmrt1heihetvu9h0iec2b4